Key facts
- ALY’s last known valuation is $8.2M (Jul 2025).
- It has raised $3.1M; the latest was Early Stage VC ($1.0M) in Jul 2025.
- Notable investors include Beyond Next Ventures, Nanto Capital Partners, Archetype Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for ALY
- ·The full record, as it builds
Funding rounds
No funding rounds for ALY are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ALY
Developer of a medical collaboration platform designed to handle data business in the healthcare field. The company's platform assists with medical device infrastructure and more using AI, enabling healthcare businesses to promote data sharing and consumption.
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Founded
- 2021
- Website
- aly.ai/
- Ownership
- Privately Held (backing)
ALY doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ALY shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ALY in its N-PORT filings yet. We sweep new filings monthly.